SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-006826
Filing Date
2024-09-05
Accepted
2024-09-05 16:27:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4247
  Complete submission text file 0001950047-24-006826.txt   6009
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Subject) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39856 | Film No.: 241281728
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CULLINAN MANAGEMENT, INC. ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address
Michaelson Jennifer (Reporting) CIK: 0001838061 (see all company filings)

Type: 144